|

Risk Stratification Value of Biomarkers in Patients With Myocarditis

RECRUITINGSponsored by First Affiliated Hospital Xi'an Jiaotong University
Actively Recruiting
SponsorFirst Affiliated Hospital Xi'an Jiaotong University
Started2023-08-25
Est. completion2030-07-31
Eligibility
Age3 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06010199

Summary

The aim of this study is to collect clinical data and biological specimens from patients with myocarditis and construct a predictive model for the prognosis of myocarditis.

Eligibility

Age: 3 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* All patients should meet the diagnostic criteria for myocarditis
* Patients who are regularly followed up at the corresponding cardiovascular center

Exclusion Criteria:

* Age \<3 years or \>80 years
* Pregnant or lactating women
* The patient refused to sign the informed consent and refused to participate in the study
* None of the above is consistent, but the patient cannot sign the informed consent temporarily due to coma and other reasons, and there is no legal representative to sign it instead. Depending on the condition, the patient may not wake up to sign the informed consent

Conditions2

Heart DiseaseMyocarditis

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.